Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05030766 · ClinicalTrials.gov registry record · Phase 4
Testing Integrative Smoking Cessation for HIV Patients
A Phase 4 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 95
- Enrollment target
NCT05030766 is a Phase 4 study that has completed, run by University of Miami. The registered enrollment target is 95 participants.
The verdict
NCT05030766, a Phase 4 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 95 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the feasibility, acceptability and effect of a combined smoking cessation intervention integrating contingency management (reward-based) strategies with Mindfulness training to identify the optimal dynamic strategy to promote smoking cessation among HIV patients.
Interventions
- DRUG Nicotine Replacement Therapy
- BEHAVIORAL Mindfulness Training Smoking Cessation Intervention
- BEHAVIORAL Contingency Management Smoking Cessation Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2024-05-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05030766
The ClinicalTrials.gov registry entry for NCT05030766 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine Replacement Therapy is the first listed.
NCT05030766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05030766 about?
NCT05030766 is a clinical study titled "Testing Integrative Smoking Cessation for HIV Patients". The purpose of this study is to examine the feasibility, acceptability and effect of a combined smoking cessation intervention integrating contingency management (reward-based) strategies with Mindfulness training to identify the optimal dynamic strategy to promote smoking cessation among HIV patien...
What is the current status of trial NCT05030766?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 95 participants. The study started on 2022-01-04. Estimated completion is 2024-05-23.
What interventions are being tested in trial NCT05030766?
The interventions under investigation include: Nicotine Replacement Therapy (DRUG), Mindfulness Training Smoking Cessation Intervention (BEHAVIORAL), Contingency Management Smoking Cessation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05030766?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.